Login / Signup

A PD-L2-based immune marker signature helps to predict survival in resected pancreatic ductal adenocarcinoma.

Yiyin ZhangJin XuJie HuaJiang LiuChen LiangQingcai MengMiaoyan WeiBo ZhangXian-Jun YuSi Shi
Published in: Journal for immunotherapy of cancer (2019)
Our work highlighted PD-L2 as a promising immunotherapeutic target with prognostic value combined with complex tumor infiltrating cells in PDAC.
Keyphrases
  • induced apoptosis
  • cell cycle arrest
  • endoplasmic reticulum stress
  • free survival
  • oxidative stress
  • signaling pathway